Sarasota, FL -- (SBWIRE) -- 08/30/2018 -- Zion Market Research has published a new report titled "Hepatitis B Diagnostic Tests Market by Product Type (Point-of-care Testing Kits [Cassettes/Cards and Strips] and Enzyme Immunoassay Kits [Anti-hepatitis B core antibody test, Hepatitis B surface antigen test, Anti-hepatitis B surface antibody test]) and by End User (Hospitals, Diagnostic Centers, Clinics, and Home Care): Global Industry Perspective, Comprehensive Analysis and Forecast, 2017 - 2024". According to the report, global Hepatitis B diagnostic tests market was valued at approximately USD 660 million in 2017 and is expected to generate revenue of around USD 1020 million by end of 2024, growing at a CAGR of around 6.5% between 2018 and 2024.

Request Free Sample Report @ https://www.zionmarketresearch.com/sample/hepatitis-b-diagnostic-tests-market

Hepatitis B is a common and serious infectious disease of the liver, which is affecting millions of people in the entire world and the prevalence of the disease has been growing globally. In 2015, about 887,000 people died due to hepatitis. In 2017, the World Health Organization (WHO) stated that about 257 million people were suffering from hepatitis B. An increased prevalence of hepatitis B is witnessed in the African and Western Pacific regions where 6.1% and 6.2% of the adult population is affected.

The global hepatitis B diagnostic tests market is segmented into its product type, end-user, and by geography. Based on product type, the hepatitis B diagnostic tests market is segmented into enzyme point of care testing kits and immunoassay kits. The point of care testing kits segment is sub-segmented into strips and cards/cassettes, and the enzyme immunoassay kits segment is further segmented into anti-hepatitis B core antibody test, hepatitis B surface antigen test, and anti-hepatitis B surface antibody test. Based on product type, the enzyme immunoassay kits segment accounted for the highest share in the global hepatitis B diagnostic tests market in 2017 and it is expected to remain dominant over the forecast period.

Inquiry more about this report @ https://www.zionmarketresearch.com/inquiry/hepatitis-b-diagnostic-tests-market

On the basis of the end-user, the hepatitis B diagnostic tests market is segmented into hospitals, diagnostic centers, clinics, and home care settings. The diagnostic center segment accounted for the significant share in the global hepatitis B diagnostic tests market and is expected to register the highest growth over the forecast period.

North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa are key regional segments of global hepatitis B diagnostic tests market. The Asia Pacific and North America are estimated to remain the leading regions in the global hepatitis B diagnostic tests market over the forecast period.

Some of the key players in the hepatitis B diagnostic tests market include Bio-Rad Laboratories, Inc., bioMérieux SA, Abbott Laboratories, Biogate Laboratories Ltd., DiaSorin S.p.A., Vista Diagnostics International, Meridian Bioscience, Inc., J.Mitra & Co. Ltd., General Biologicals Corporation, and Siemens Medical Solutions USA, Inc.

Browse the full "Hepatitis B Diagnostic Tests Market" report at https://www.zionmarketresearch.com/report/hepatitis-b-diagnostic-tests-market

This report segments the global hepatitis B diagnostic tests market as follows:

Global Hepatitis B Diagnostic Tests Market: Product Type Segment Analysis

Enzyme Immunoassay Kits
Anti-hepatitis B core antibody test
Hepatitis B surface antigen test
Anti-hepatitis B surface antibody test
Point-of-care Testing Kits
Strips
Cassettes/Cards

Global Hepatitis B Diagnostic Tests Market: End-User Segment Analysis

Hospitals
Diagnostic Centers
Clinics
Home Care

Global Hepatitis B Diagnostic Tests Market: Regional Segment Analysis

North America
The U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
The Middle East and Africa